According to Jeremy Unrah, PharmaCann general counsel, the deal is one way for the company to raise money due to the financing challenged in the cannabis industry. “You don’t get construction loans like normal companies,” he said in the report. Cannabis Real Estate Investor Trust Files for NYSE Listing

thumbnail courtesy of